Skip to main content
. Author manuscript; available in PMC: 2018 Apr 9.
Published in final edited form as: J Matern Fetal Neonatal Med. 2014 Jan 6;27(10):975–983. doi: 10.3109/14767058.2013.847918

Figure 2.

Figure 2

Amniotic fluid secreted phospholipase A2 concentration (sPLA2) among women with MSAF at term with presence and absence of endotoxin or microorganisms. Patients with MSAF and intra-amniotic inflammation/infection at term had a significantly higher median secreted phospholipase A2 concentration (ng/mL) than those without intra-amniotic inflammation/infection [2.4 (1.7–6.99) versus 1.7 (1.3–2.5); p = 0.049].